# Observation vs Progesterone Treatment for Management of Uterine Arteriovenous Malformation

> **NCT05491343** · PHASE4 · UNKNOWN · sponsor: **HaEmek Medical Center, Israel** · enrollment: 28 (estimated)

## Conditions studied

- Arteriovenous Malformations

## Interventions

- **DRUG:** MedroxyPROGESTERone Injection [Depo-Provera]
- **DEVICE:** Other

## Key facts

- **NCT ID:** NCT05491343
- **Lead sponsor:** HaEmek Medical Center, Israel
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-08
- **Primary completion:** 2022-12
- **Final completion:** 2024-01
- **Target enrollment:** 28 (ESTIMATED)
- **Last updated:** 2022-08-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05491343

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05491343, "Observation vs Progesterone Treatment for Management of Uterine Arteriovenous Malformation". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05491343. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*